Budget Impact Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

This study aims to perform a budget impact analysis of the use of three available novel oral anticoagulant agents (NOACs) for preventing thromboembolic events in Italian patients with non-valvular atrial fibrillation (NVAF).

Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: L. Pradelli, M. Calandriello, Virgilio R. Di, M. Bellone, M. Tubaro Source Type: research